Stoneridge, Inc.·Consumer Cyclical

LONDON--(BUSINESS WIRE)--Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selecti.

Stoneridge, Inc. (SRI) Q1 2026 Earnings Call Transcript

Q1 Performance Demonstrates Solid Progress Continued Strong Momentum with Program Awards for MirrorEye ® and Electronic Controls NOVI, Mich., May 7, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) today announced financial results for the first quarter ended March 31, 2026.

NOVI, Mich., May 4, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) will webcast its first quarter 2026 earnings conference call live on Thursday, May 7, 2026, at 9:00 a.m.

NOVI, Mich., April 28, 2026 /PRNewswire/ -- Driven by accelerating global demand for advanced vision systems, Stoneridge, Inc. (NYSE: SRI) has achieved significant milestones for its award-winning MirrorEye ® Camera Monitor System (CMS), underscoring the company's strong market momentum and continued innovation in commercial vehicle safety and efficiency.

Stoneridge remains a "Buy" despite recent revenue and profit declines, driven by optimism around MirrorEye and long-term growth prospects. Recent results were weak, with 2025 revenue down 6% and net loss widening, but impairment charges and income taxes drove much of the deterioration. MirrorEye revenue grew 69% year-over-year to $111 million, with management projecting significant incremental growth and new business awards totaling $830 million.
Stoneridge, Inc., together with its subsidiaries, designs and manufactures engineered electrical and electronic components, modules, and systems for the automotive, commercial, off-highway, motorcycle, and agricultural vehicle markets in North America, South America, Europe, and internationally. It operates in three segments: Control Devices, Electronics, and Stoneridge Brazil. The Control Devices segment offers sensors, switches, actuators, and connectors that monitor, measure, or activate specific functions within a vehicle. The Electronics segment designs and manufactures driver information systems, camera-based vision systems, connectivity, and compliance products. Its products collect, store, and display vehicle information, such as speed, pressure, maintenance data, trip information, operator performance, temperature, distance traveled, and driver messages related to vehicle performance. This segment's electronic control units regulate, coordinate, monitor, and direct the operation of the electrical system within a vehicle. The Stoneridge Brazil segment designs, manufactures, and sells vehicle tracking devices and monitoring services; vehicle security alarms and convenience accessories; in-vehicle audio and infotainment devices; and telematics solutions. It provides its products and systems to various original equipment manufacturers and Tier 1 customers, as well as aftermarket distributors and mass merchandisers for use in various vehicle platforms. Stoneridge, Inc. was founded in 1965 and is headquartered in Novi, Michigan.
Consumer Cyclical
Auto - Parts
4,450
1997-10-10
1.85